SEC Form 4 · accession 0001844320-26-000013
Oscar Health, Inc. · OSCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mario Schlosser
Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 4:11 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001568651
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2,F3 | Jul 1, 2026 | C | 47,500 | — | A | 47,500 | I | By Pizzo-Schlosser Family Dynasty Trust |
| Class A Common StockF4,F3 | Jul 1, 2026 | S | 3,600 | $29.50 | D | 43,900 | I | By Pizzo-Schlosser Family Dynasty Trust |
| Class A Common StockF5,F3 | Jul 1, 2026 | S | 13,672 | $30.80 | D | 30,228 | I | By Pizzo-Schlosser Family Dynasty Trust |
| Class A Common StockF6,F3 | Jul 1, 2026 | S | 30,228 | $31.65 | D | 0 | I | By Pizzo-Schlosser Family Dynasty Trust |
| Class A Common StockF7 | holding | — | — | — | 480,866 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF2,F3 | — | Jul 1, 2026 | C | 47,500 | D | — | — | Class A Common Stock | 47,500 | 538,333 | I |
| Class B Common StockF3,F2 | — | holding | — | — | — | — | — | Class A Common Stock | 283,333 | 283,333 | I |
| Class B Common StockF3,F2 | — | holding | — | — | — | — | — | Class A Common Stock | 283,333 | 283,333 | I |
| Class B Common StockF2 | — | holding | — | — | — | — | — | Class A Common Stock | 1,212,293 | 1,212,293 | D |
Explanation of responses
- F1The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026.
- F2The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
- F3Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $31.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- F7Includes shares to be issued in connection with the vesting of one or more restricted stock units.